Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC9A1 | P19634 | 4/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HCAR3 | P49019 | 1/20 | 0.32 |
| ▸ | CNR1 | P21554 | 1/20 | 0.32 |
| ▸ | CNR2 | P34972 | 1/20 | 0.32 |
| ▸ | SMPD1 | P17405 | 4/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5273217 | 0.94 | SLC9A1 (0.37) | SLC9A1HCAR3GRM2 | |
| SCHEMBL5286326 | 0.90 | SLC9A1 (0.39) | SLC9A1MAPTHCAR3CNR1CNR2 | |
| SCHEMBL5275508 | 0.87 | SLC9A1 (0.34) | SLC9A1ALDH1A1GRM2 | |
| SCHEMBL5279359 | 0.86 | SLC9A1 (0.41) | SLC9A1MAPTHCAR3CNR1CNR2 | |
| SCHEMBL5276454 | 0.85 | SLC9A1 (0.40) | SLC9A1MAPTHCAR3CNR1CNR2 | |
| SCHEMBL5281344 | 0.83 | SLC9A1 (0.36) | SLC9A1HCAR3GRM2 | |
| SCHEMBL5284459 | 0.82 | SLC9A1 (0.38) | SLC9A1MAPTHCAR3CNR1CNR2 | |
| SCHEMBL5278300 | 0.81 | SLC9A1 (0.44) | SLC9A1MAPTHCAR3CNR1CNR2 | |
| SCHEMBL5281693 | 0.80 | SLC9A1 (0.31) | SLC9A1 | |
| SCHEMBL5286379 | 0.80 | SLC9A1 (0.38) | SLC9A1HCAR3CNR1CNR2GRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1859781-A2 | Brightening and/or colouring agent with triazoles | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-11-28 | — | — | EP | disclosed |